Skip to content

Dr. Reddy’s launches generic Faslodex Injection in U.S.

September 7, 2020

Dr. Reddy’s Laboratories (NYSE:RDY) announces the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent generic version of AstraZeneca’s (NYSE:AZN) FDA approved Faslodex (fulvestrant) Injection, 250 mg/5 mL (50 mg/mL).

Per IQVIA, the U.S. market is ~$­­­­­407M.

https://seekingalpha.com/news/3611953-dr-reddys-launches-generic-faslodex-injection-in-u-s

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: